159 related articles for article (PubMed ID: 32058215)
1. Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using
Liu C; Li Y; Qin X; Yang Z; Luo J; Zhang J; Gray B; Pak KY; Xu X; Cheng J; Zhang Y
Biomed Pharmacother; 2020 May; 125():109947. PubMed ID: 32058215
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
[TBL] [Abstract][Full Text] [Related]
3.
Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
[TBL] [Abstract][Full Text] [Related]
4. [
Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y
Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.
Elvas F; Vangestel C; Rapic S; Verhaeghe J; Gray B; Pak K; Stroobants S; Staelens S; Wyffels L
Mol Imaging Biol; 2015 Dec; 17(6):838-47. PubMed ID: 25896815
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using
Delvaeye T; Wyffels L; Deleye S; Lemeire K; Gonçalves A; Decrock E; Staelens S; Leybaert L; Vandenabeele P; Krysko DV
J Nucl Med; 2018 Jul; 59(7):1140-1145. PubMed ID: 29419481
[TBL] [Abstract][Full Text] [Related]
7. Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With 99mTc-Labeled Duramycin SPECT/CT.
Luo R; Niu L; Qiu F; Fang W; Fu T; Zhao M; Zhang YJ; Hua ZC; Li XF; Wang F
Mol Imaging; 2016; 15():. PubMed ID: 27030401
[TBL] [Abstract][Full Text] [Related]
8. [
Palmieri L; Elvas F; Vangestel C; Pak K; Gray B; Stroobants S; Staelens S; Wyffels L
Nucl Med Biol; 2018 Jan; 56():1-9. PubMed ID: 29031229
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of [
Gu B; Liu S; Sun Y; Zhang J; Zhang Y; Xu X; Yuan H; Wang M; Zhang Y; Yang Z
Mol Imaging Biol; 2019 Jun; 21(3):538-548. PubMed ID: 30218389
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Song S; Xiong C; Lu W; Ku G; Huang G; Li C
J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
[TBL] [Abstract][Full Text] [Related]
11. Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.
Kawai H; Chaudhry F; Shekhar A; Petrov A; Nakahara T; Tanimoto T; Kim D; Chen J; Lebeche D; Blankenberg FG; Pak KY; Kolodgie FD; Virmani R; Sengupta P; Narula N; Hajjar RJ; Strauss HW; Narula J
JACC Cardiovasc Imaging; 2018 Dec; 11(12):1823-1833. PubMed ID: 29454770
[TBL] [Abstract][Full Text] [Related]
12. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.
Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM
Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285
[TBL] [Abstract][Full Text] [Related]
13.
Tan H; Abudupataer M; Qiu L; Mao W; Xiao J; Cheng D; Shi H
Chem Biol Drug Des; 2021 Feb; 97(2):210-220. PubMed ID: 32881342
[TBL] [Abstract][Full Text] [Related]
14. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preclinical investigation of
Shah SQ; Gul-E-Raana
Mol Biol Rep; 2019 Apr; 46(2):1675-1682. PubMed ID: 30680596
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma.
Lin M; You R; Liu YP; Zhang YN; Zhang HJ; Zou X; Yang Q; Li CF; Hua YJ; Yu T; Cao JY; Li JB; Mo HY; Guo L; Lin AH; Sun Y; Qian CN; Ma J; Mai HQ; Chen MY
Oral Oncol; 2018 May; 80():1-8. PubMed ID: 29706183
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model.
Wang L; Wang F; Fang W; Johnson SE; Audi S; Zimmer M; Holly TA; Lee DC; Zhu B; Zhu H; Zhao M
Nucl Med Biol; 2015 Feb; 42(2):198-204. PubMed ID: 25451214
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
You R; Hua YJ; Liu YP; Yang Q; Zhang YN; Li JB; Li CF; Zou X; Yu T; Cao JY; Zhang MX; Jiang R; Sun R; Mo HY; Guo L; Cao KJ; Lin AH; Sun Y; Qian CN; Ma J; Chen MY
Theranostics; 2017; 7(8):2314-2324. PubMed ID: 28740554
[TBL] [Abstract][Full Text] [Related]
19. [Combining FCU/5-FU suicide gene/prodrug system and radiation in treating nasopharyngeal carcinoma: an experimental study].
Tang YY; Zhao SP; Xu J; Zhong Y; Xiao JY
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):483-7. PubMed ID: 17069702
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of [
Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H
Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
